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Background: Family planning is an important public health intervention with numerous potential health benefits
for all women. One of those key benefits is the prevention of mother-to-child transmission of HIV, through the
prevention of unintended pregnancies among women living with HIV.
Methods: We conducted a systematic review of the effectiveness of family planning counseling interventions for
HIV infected women in low- and middle-income countries.
Results: We found nine articles which met the inclusion criteria for this review, all from Africa. Though these
studies varied in the specifics of the interventions provided, research designs and measures of outcomes, key
features were discernible. Providing concerted information and support for family planning use, coupled with ready
access to a wide range of contraceptive methods, seemed most effective in increasing use. Effects on pregnancy
overall were difficult to measure, however: no studies assessed the effect on unintended pregnancy.
Conclusions: Though these results are far from definitive, they do highlight the need for strengthened efforts to
integrate family planning counseling and access to services into HIV prevention, and for greater consistency of
effort over time. Studies which specifically investigate fertility intentions and desires of women living with HIV,
contraception use following interventions to increase knowledge, awareness, motivation and access to the means
to act on those intentions and unintended pregnancies would be valuable to help clinic personnel, programme
planners and policy makers guide the development of the integrated services they offer.
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An estimated 34 million people were living with HIV in
2011 [1]. Of these, nearly three and a half million were
children under the age of 15, the great majority of whom
lived in sub-Saharan Africa and were likely to have been
infected at birth. In 2011, an estimated 330,000 children
were newly infected with HIV globally, more than 90%
of them through mother-to-child transmission [1]. With
the interventions currently recommended by WHOa the
risk of mother to child transmission can be reduced to* Correspondence: oreillyk@who.int
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reproduction in any medium, provided the orless than 2% in non-breastfeeding settings, and to 5% or
less in breastfeeding populations [2].
The United Nations has recently set a goal of reducing
the number of new HIV infections among children by
90% and the number of AIDS-related maternal deaths by
50% by 2015 [3]. To prevent mother to child transmission,
the World Health Organization (WHO) promotes four
key elements: [1] the primary prevention of HIV infection
in women of childbearing age, especially young women [2]
the prevention of unintended pregnancies in women living
with HIV, [3] the prevention of vertical transmission from a
woman living with HIV to her infant, and [4] the provision
of treatment, care and support to mothers living with HIV
and their children and families [4,5]. These efforts haveLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
O’Reilly et al. BMC Public Health 2013, 13:935 Page 2 of 10
http://www.biomedcentral.com/1471-2458/13/935been guiding PMTCT programmes in the last decade.
Strengthening attention to this goal at country level has
become a key priority.
Global PMTCT efforts have focused primarily on the
third element of the PMTCT strategy: the provision of
antiretroviral drugs to pregnant women living with HIV
to prevent vertical transmission. In its newest guidance,
PEPFAR has stated that funds may not be used to pur-
chase family planning commodities but can be used to
support integration of family planning services and HIV
prevention in PEPFAR-funded PMTCT and HIV care
and treatment programmes, using commodities funded
by sources other than PEPFAR [6]. The availability of
those funds from other sources has also been limited.
Contraception offers a range of health benefits to all
women and their families, not just to those living with
HIV [7]. Several authors have highlighted the substantial
contribution that family planning can make to reducing
mother-to-child transmission of HIV by decreasing the
frequency of unintended pregnancies among women
living with HIV [8,9]. At the global level, policy support
for the integration of reproductive health, especially family
planning, into HIV/AIDS programmes, especially PMTCT,
has been established [10-12]. Essential services for pre-
venting unintended pregnancies among women living with
HIV have been defined [13]. In addition, family planning
for women living with HIV not only can help prevent
mother-to-child HIV transmission, but also can provide
additional health and social benefits for women and their
children. Coupled with an increasingly strong call for re-
spect of the human rights and reproductive choices of
women living with HIV [14], accelerated efforts to reduce
new HIV infections in children now call for strengthened
integration of reproductive health services, especially
family planning services, and HIV/AIDS programmes.
Given this increased emphasis on integration at the glo-
bal and programmatic level, we undertook a systematic
review of the evidence of family planning counseling for
women living with HIV, specifically the effect of inter-
ventions on increasing contraceptive use and decreasing
the incidence of unintended pregnancy.
Methods
This review is part of a series of systematic reviews of
HIV behavioral interventions in low- and middle-income
countries conducted for the Evidence Project, a collab-
oration between the World Health Organization, the
Medical University of South Carolina, and the Johns
Hopkins Bloomberg School of Public Health. Other inter-
ventions that have been systematically reviewed through
the Evidence Project include voluntary counseling and
testing (VCT) [15], mass media [16], psychosocial sup-
port [17], treatment as prevention [18], peer education
[19], positive prevention [20], condom social marketing[21] and provider-initiated testing and counseling [22].
For this project, we follow established PRISMA reporting
guidelines [23] and use standardized methods across re-
views. In this review, we sought to answer the question, in
low and middle income countries, what is the impact of
family planning counseling for women living with HIV on
HIV/AIDS-related outcomes?
Inclusion criteria
Inclusion criteria for articles were as follows:
1) Published in a peer-reviewed journal.
2) Intervention provided family planning counseling
(one-on-one counseling, not just health education)
to HIV-infected women. Articles included could
either: [1] present data from HIV-infected women
only, or [2] present data from both HIV-infected
and HIV-uninfected women. To be included in the
review, articles in the second category had to
present pre-intervention / post-intervention or
multi-arm data separately for HIV-infected women.
3) Analysis used a pre/post or multi-arm design,
comparing individuals who received family planning
counseling to those who did not to allow an
assessment of post-intervention outcomes of interest.
4) Analysis included at least one HIV-related
behavioral, psychological, social, care or
biological outcome. For purposes of this review
we included pregnancy in women living with
HIV as an “HIV-related” biological outcome.
5) Study conducted in a low, lower-middle, or upper-
middle income country, according to the World Bank
country classification scheme.
No restrictions were placed based on location or set-
tings of the intervention. No language restrictions were
used on the search; studies identified in languages other
than English were translated for inclusion.
Study designs
Any pre-post or multi-arm intervention study comparing
individuals or groups who received family planning coun-
seling to those who did not was included for review. Fam-
ily planning counseling was defined as more than
information or education about contraception; health
education or the provision of factual information with-
out personal counseling was not sufficient for inclusion.
Family planning counseling could be linked to or part of
VCT activities, or to HIV care and treatment, or could be
provided independently. Studies were included if they
sampled either individuals or groups who received the
intervention versus those in a control or comparison
group, or individuals or groups before and after receiv-
ing the intervention.
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We searched PubMed, PsycINFO, Sociological Abstracts,
CINAHL (Cumulative Index to Nursing and Allied Health
Literature), and EMBASE using the date ranges January 1,
1990 to December 31, 2011. In addition, we reviewed the
table of contents of four journals: AIDS, AIDS and Behavior,
AIDS Education and Prevention, and AIDS Care. Secondary
reference searching was conducted on the reference lists
of articles included in the study.
Search terms
The following search terms were entered into each
online database: (“family planning” OR “birth control”
OR contraceptive OR contraception OR fertility OR
“reproductive counselling” OR “reproductive counseling”
OR “reproductive planning” OR “birth spacing”) AND
(HIV-infected OR HIV-positive OR “women living with
HIV” OR “people living with HIV” OR “HIV seropositive”
OR “infected with HIV” OR “living with AIDS” OR “HIV
seropositivity”).
Screening abstracts
Citations identified through the search strategy were
initially reviewed for inclusion based on information
contained in titles, abstracts, citation information, and
key words by a single reviewer. The relevant citations
were then independently screened by two reviewers to
determine eligibility. Full text articles were obtained for
all eligible studies and for those which needed further
review to determine eligibility. Background articles that
contained relevant information but did not meet the
inclusion criteria were also obtained.
Data extraction and management
Two reviewers extracted data independently using stan-
dardized data extraction forms. Differences in data extrac-
tion were resolved through consensus and discussion with
a senior study team member when required.
Data extraction forms gathered the following informa-
tion from each included study: location, setting & target
group; years (period of study); description of the interven-
tion; study design; sample size; age range, gender; random
or non-random allocation of participants; length of follow-
up; outcome measures; comparison groups; effect sizes;
confidence intervals; significance levels; and limitations
identified by authors and reviewers. Study quality (rigor)
was assessed based on an 8-item list developed by The
Evidence Project for similar reviews. Background studies
were assessed using a greatly simplified data extraction form.
Data analysis
Data were analyzed descriptively; meta-analysis could not
be conducted due to the heterogeneity of interventions,
populations, measured outcomes, and study designs.Results
An initial search of the literature resulted in 4292 unique
citations (Figure 1). These were screened for eligibility
and 4250 were removed for failing to meet the inclusion
criteria. The remaining 42 articles were determined to
merit closer study to determine their eligibility for in-
clusion in the systematic review. Of these, nine were
found to meet all the inclusion criteria and these form
the basis of this systematic review. Twenty-five add-
itional articles were included as background articles of
importance.
All nine included studies were conducted in Africa:
two in Rwanda [24,25], two in Zambia [26,27], two in
Kenya [28,29] and one each in Côte d’Ivoire [30], Malawi
[31], and Uganda [32] (Table 1). The study designs for
the studies included time series analysis [24,30], before/
after intervention study designs without a control group
[25,26,31], a prospective cohort design [32], a retrospective
cohort [29], a non-randomized trial [28] and a controlled
trial with group randomization [27]. The mean length of
follow-up also varied, from 161 days [25] up to two years
[24,28,30,32]. While all studies had pre-post intervention
data and all but one followed a cohort of individuals over
time, three studies had a control or comparison group, two
studies randomly selected participants for assessment and
only one randomly assigned groups of participants (cou-
ples) to study arms [27].
The study populations in the nine studies were drawn
from pediatric and perinatal clinics at a major urban
hospital [24,25], from a PMTCT programme [30], from
clinics that provided family planning, sexually transmitted
disease services, or VCT [31], from HIV treatment and
care clinics [26,29], from a home-based care study [32] and
from an HIV prevention trial sites [27,28]. Some of the
studies focused exclusively on unique populations, includ-
ing HIV seropositive women [26,29,30,32], serodiscordant
couples (presenting data from HIV-infected women separ-
ately in the analysis) [27,28] or women of unknown status
who were tested and counselled as part of the study
[24,25,31]. Three of the studies offered counselling and
follow-up to partners and couples as well [24,25,27,28].
The interventions reported in these studies varied in
the access to contraceptives offered, in both the range of
contraceptives available as well as the ease of access. In
some studies, a variety of modern contraceptive methods,
using the WHO definition [33], was provided on site free
of charge [25-29]. In others, a reduced range of contracep-
tives on site was offered [24] or referral to family planning
services was made [32]. In two studies, either the issue
of access was not addressed [31] or it was not clear where
the access to contraceptives was provided [30]. Studies
which provided a broader range of contraceptive options
seemed to result in increased use of contraception com-
pared to those that offered referral or access to a reduced
Citations identified 
through online database 
searches (N=5724)
Citations identified 
through other sources 
(N=12) 
Citations screened (N=4292) 
Full-text articles retrieved to 
determine eligibility (N=42) 
Articles included in the 
review (N=9) 
Articles excluded after full-text review 
(N=33) because:
No intervention took place (N=1)
No pre/post or multi-arm comparisons (N=5)
HIV status of participants was not 
differentiated (N=2)
Articles coded as background (N=25)




Figure 1 Family planning for HIV positive women: flow chart depicting disposition of study citations (Search Dates: January 1,
1990- January 5, 2012).
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quantify this comparison.
The studies also varied in the nature and content of
the intervention offered. In the study by Allen et al. in
Rwanda [24], participants were shown a thirty-five minute
pretest counselling video about AIDS and modes of
transmission, as well as a demonstration of condom and
spermicide use; women were counselled about contracep-
tion only if they requested it. King et al. [25] presented
participants a fifteen minute educational video on contra-
ception, followed by group discussion. Stephenson et al.
[27] presented two different thirty-minute video-based
family planning interventions. In other studies, however,
counselling about contraception was limited and consisted
mainly of informing women of the effect of antiretroviral
drugs on fertility and sexuality with referral to a nearby
family planning clinic [32].
More intensive family planning counselling was also of-
fered in some studies. This ranged from including family
planning in the post-test HIV counselling, pre-natal and
post-natal visits, as was done in the study reported byBrou et al. [30], to the most intensive, a multi component
strategy that included male partners in family planning
counselling and extensive staff training. Weekly meetings
on family planning for all staff, use of checklists to prompt
family planning discussions, discussions of challenges to
use with participants individually and in groups, and re-
view of unintended pregnancies to identify ways to im-
prove the intervention were held [28]. This intervention
in Kenya, reported by Ngure et al., resulted in a stronger
and more durable effect than was seen in the comparison
clinics in the same study or in the other less intensive in-
terventions presented in the other studies reviewed here.
Other studies followed a similar strategy of deploying the
personnel most experienced in family planning in the HIV
treatment and care facilities [26,29], though the outcomes
observed were generally less than those seen with the
more intensive intervention reported in the Ngure study.
All nine studies measured changes in use of contra-
ception, variously defined as “hormonal contraception
use”, “modern contraception use” and “non condom
contraception use”. In addition, four studies [25,28,29,31]
Table 1 Family planning counseling for HIV positive women—final study description
Study Setting Population
characteristics
Intervention description Study design Key outcomes reported





HIV testing; 35 minute AIDS educational
video, followed by a group discussion.
Condoms and spermicide were
distributed at no charge. In-depth
counseling provided for HIV-infected
women, including discussion of family
planning measures for those who
requested.
Time series study design.
Assessments at baseline
(N = 1458), 12 months
(N = 1254), and 24 months
(N = 1352). Stratified random
sampling from a consecutive
sample of women presenting
to prenatal and pediatric clinics.
Hormonal contraception use
Kigali Age Range: 18-35
years
Baseline: 23%
12 months: 16% (significance not reported)
Brou et al., 2009 Ivory Coast Pregnant women
presenting for
PMTCT
HIV testing. Offered post-test and post-
partum family planning during follow up
visits, as well as information on sexually
transmitted infections (STIs), including
HIV/AIDS, and condom use. Postpartum
free access to modern contraceptive
methods (injectable contraceptives,
contraceptive pills, and condoms) from
first month.
Time series study design.
Assessments at baseline
(N = 980) and at 3, 6, 12, 18










24 months: 52% (significance not
reported)
Chibwesha et al., 2011 Zambia Women living with
HIV on ART
Trained 109 peer counselors to deliver
standardized counseling message in
context of clinical care, emphasizing dual
methods. Referral to separate, on-site
family planning department or surgical
facility for permanent methods
Before/after study design
with no control group.
Not clear how long was
period from baseline to
follow up. Non-random







Post counseling: 9.8% non-users want
contraception; 61.% of these access FP
services in 90 days
Hoffman et al., 2008 Malawi Women living with
HIV
Pregnancy testing, VCT, and FP
counseling.
Before/after study design
with no control group.
Participants were followed
for 1 year, with assessments
at baseline (N = 227), 1 week,
and 1, 3, 6, 9 and 12 months
after VCT. N = 200 at study
completion. Non-random




26 years (IQR: 23
to 30 years)
Baseline: 38%
12 months: 46% ns
Pregnancy incidence:
Post only: 14.5 per 100 py
Homsy et al., 2009 Uganda Women living with
HIV on ART
Home Based AIDS Care with referral to
government family planning clinic for
counseling and contraceptive options.
Weekly home visits to manage treatment
adherence, monitor clinical signs and
refer to clinics as needed.
Prospective cohort design study
to compare reproductive intentions,
identifying risk factors of pregnancy,
contraceptive use, incidence of
pregnancy among HIV +women on
ART. Assessment at baseline (N = 708)
and at 3, 6, 9, 12, 15, 18, 21, 24 (N = 656)
and 27 months. Non-random selection
of study participants.
All contraceptive use:




King et al., 1995 Rwanda Women attending
pediatric and
prenatal clinics
VCT followed by a 15 minute educational
video on contraceptive methods and
group discussion. Contraceptive pills,
injectable progestins, and Norplant
Before/after study design with no
control group. Assessments at baseline






















Table 1 Family planning counseling for HIV positive women—final study description (Continued)
provided free of charge to women who
chose to enroll in the FP program.
(the mean length of follow-up
was 161 day for hormonal











Kosgei et al., 2011 Kenya HIV + women in
AIDS care
(39% on ART)
FP services integrated into HIV care in
one clinical team; nurses experienced in
offering FP services relocated to HIV
clinical team; on site delivery of all FP
methods except surgical
Retrospective cohort study.
Mean (SD) of follow up:
342 days (155) for integrated
family planning and 361 day
(147) for routine care
Comparing intensified FP to regular
care: new condom use: 16.7% increase,
new FP use including condoms: 12.9%
increase;
Eldoret Age: mean 32.7,
SD 7.2
new FP use excluding condoms: 3.8%
decrease; (all significant),
New pregnancies: 0.1% increase (ns)
Ngure et al., 2009 Kenya Women in HIV
serodiscordant
relationships
Free contraceptive methods [oral
contraceptive pills, injectables, implants,
and intrauterine devices (IUDs)],
contraceptive appointment cards to avoid
lapses in hormonal contraception,
couples and individual contraceptive
counseling sessions during routine study
visits
Non-randomized trial comparing
intervention to comparison group,
stratifying by HIV serostatus.
Assessments at baseline (N = 1429)
and 3-months (N not reported).
Non-random selection of study
participants (cluster sampling).







Follow up: 64.7% visits
Pregnancy incidence:
Intervention pre: 13.5 per 100 py
Intervention post: 8.7 per 100 py (sig)
HIV negative comparison pre: 21.1
per 100 py
HIV- comparison post: 11.0 per
100 py (sig)
(Increased in both groups at other sites
without intensive intervention)






Two different video-based family
planning interventions: information on
contraceptive methods, with emphasis on
IUD and implant; motivational video
modeling desirable future planning
behaviours, including pregnancy
prevention; on-site access to most
methods
Group randomized trial to one
of four arms: control, methods
only, motivation only, motivation
plus methods, No time specified
for pre and post intervention
follow up
Motivational and method arm likely to
adopt injectables than OCPs: RRR = 1.65
(CI 1.07-3.44); methods arm more likely
to adopt injectables than OCPs: RRR =
1.55, CI 1.03-2.34). Pregnancy outcomes
not studied
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comparisons between pre- to post-intervention for sero-
positive women, between seropositive and seronegative
women, or between seropositive women at intervention
sites to seropositive women in non-intervention sites.
All nine studies reported changes in contraception use
over time. Though significance figures for pre- to post-
changes in contraception use by women living with HIV
were not always presented, all but two studies [24,32]
presented clear evidence of increases in contraception use
by women living with HIV, either compared to a baseline
measurement, to women who were not infected with HIV,
or to women of similar serostatus from different settings
with less intense interventions. For example, Brou et al.
[30] showed an increase in modern contraception from
46% at baseline to 65% at 12-month follow-up and 52%
at 24-month follow-up; Hoffman et al. [31] showed an
increase in all contraceptive use from 38% at baseline to
46% at 12-month follow-up; Kosgei et al. [29] found an
increase in condom use and new family planning use
including condoms; and King et al. [25] showed an in-
crease in hormonal contraceptive use from 16% at base-
line to 24% at follow-up. Only one study [24] found a
decrease in hormonal contraceptive use from 23% at base-
line to 16% at 12 month follow-up, reflecting a shift away
from hormonal contraception towards barrier methods
and spermicides in women after testing positive for HIV.
The study also suggests that lack of access to hormonal
contraception may have been a barrier to its use as only
condoms and spermicide were provided at the study
site [24]. However, the effects of the interventions
waned over time: contraception use at 24 months post-
intervention was generally lower than at earlier follow
up periods in all cases except the Ngure et al. study in
Kenya [28].
Four articles presented pregnancy incidence, calculated
as a rate per 100 person years (3 studies) or a simple
percentage. In two studies, the rate was presented as
pre- to post-intervention comparison [25,28]; significant
decreases in pregnancy incidence were found in both
studies. King et al. [25] found that pregnancy rates
declined from 22% before the intervention to 9% after.
Ngure et al. [28] found pregnancy incidence decreased
from 13.5 per 100 person years before the intervention
to 8.7 per 100 person years after the intervention; a
comparison with HIV-negative women in this study also
showed significantly decreased pregnancy incidence
among those women. Two studies presented post inter-
vention pregnancy incidence only [29,31]. In one of
these [29], the incidence of pregnancy increased slightly
(but not significantly) in the group receiving the intensi-
fied intervention. All four studies reported overall preg-
nancy incidence and did not report specifically on
unintended pregnancies.Discussion
Given the amount of attention that family planning for
women living with HIV has generated in the literature
[34], it is notable that so little evidence of the effective-
ness of the second element of the PMTCT strategy can
be found. Only nine articles over the past twenty-one
years met the inclusion criteria for this systematic review.
Seven of these articles were published in the past four
years, after a long period in which the issue apparently
received little attention in the research literature. Clearly,
increased attention to the integration of reproductive
health and HIV prevention services is attracting researchers
as well as advocates.
The evidence contained in these articles is difficult to
summarize succinctly. The study populations, interven-
tions and definition of and access to contraception all
differed across these studies. Furthermore, the research
designs and outcomes presented were different as well.
Studies also spanned several decades, thus encompassing
vastly altered settings in regards to HIV prevention pro-
gramming and treatment availability. Despite these chal-
lenges, it is possible to draw some broad conclusions.
First and foremost, the intensity of the intervention mat-
ters: women receiving more intensive interventions were
more likely to use contraception. Second, interventions
needed to be repeated or reinforced over time to avoid a
waning of effect. Without these key features, the effect-
iveness of the interventions offered decays.
Access to free contraceptive supplies was not a routine
feature of these studies. Only six of the nine studies spe-
cifically mention providing contraception on site and
free of charge [25-30]. Notably, these are the more recent
studies, perhaps indicating that access to family planning
has been recognized as a key issue in increasing family
planning use. The range of contraceptive options also
varied across these studies. Most recent studies [26-29]
included the full range of contraceptive options that would
be offered in most modern family planning clinics in the
developed world. Providing easy access to a full range of
contraceptive choices for free would seem to be important
if the goal is truly to help women living with HIV, particu-
larly women with limited means, reduce their chances of
an unintended pregnancy. This is supported by evidence
from the Contraceptive Choices study in the United States
which found that difficulty in obtaining the chosen method
contributes to high rates of discontinuation by contra-
ceptive pill, patch and ring users [35]. In similar fashion,
this systematic review suggests that those studies which
provided more immediate access to a wider range of
contraception produced somewhat better results than
those that offered referral or access to a reduced range
of contraceptives.
Preventing unintended pregnancies is the goal of
increasing contraceptive use among women living with
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incidence at all; none reported on unintended pregnan-
cies. Mathematical modelling has long suggested that the
effect of preventing unintended pregnancies in women
living with HIV can be equal to or greater than the
contribution of the provision of antiretroviral drugs to
pregnant women living with HIV in preventing HIV in
infants [9,36], even with the adoption of more effective
antiretrovirals for the prevention of vertical transmission
[37]. With renewed commitment to eliminating HIV in
infants, a corresponding increase in attention paid to
prevention of unintended pregnancies in women living
with HIV by the provision of competent family planning
services is needed [13,34]. More research to establish
the potential of this element when added to national
programmes and the operational challenges entailed is
clearly needed. Further, to strengthen the evidence base,
research that measures the effect of interventions on
the prevention of unintended pregnancies, considers the
variability of pregnancy incidence over time, and uses
experimental or quasi-experimental designs would be
beneficial.
Looking at the interventions offered in these studies
over time we observed a change in the understanding of
what motivates or facilitates contraception use in women
living with HIV. Over time, it has become more widely
recognized that women living with HIV respond to
learning about their infection in different ways [38] and
will accordingly plan their future reproduction and
make choices about contraception that best suit them
[39]. The earlier studies reviewed here offered more basic
interventions: providing women with testing and coun-
selling and knowledge of serostatus, coupled with infor-
mation about HIV transmission and how to avoid it in
pregnancy. The idea implicit in these interventions
would seem to be that women who know they are living
with HIV will decide not to reproduce and take steps to
avoid unintended pregnancies. The more recent studies,
conducted and published more than a decade later, re-
flect a more nuanced understanding of fertility inten-
tions and the factors that contribute to the desire for
more children. They may also reflect greater appreciation
of the possibility to avoid vertical transmission if women
chose to reproduce as well as a greater appreciation of the
health benefits of reproductive health services in general
for women living with HIV. In addition, the increasing
availability of antiretroviral therapy for persons living with
HIV in the countries studied may have influenced the
perspectives of women and care providers over the period
in question. Taken together, it should not be surprising
that the later studies offered more nuanced interven-
tions and strived to remove potential barriers to accessing
contraception and continuing its use, often through inte-
gration with HIV treatment and care.Conclusions
The right of reproductive choice for women living with
HIV has long been established [40,41], though signifi-
cant gaps remain between the commitment to choice
and the delivery of health services [14]. The evidence
reviewed here indicates that this right is increasingly being
recognized in the services that are being made available
to women living with HIV, while simultaneously raising
the question if these services are widely available. It also
suggests a recognition that as circumstances and desires
for more children change over the course of a woman’s
life, more comprehensive interventions of longer dur-
ation are needed.
Despite increased recognition of the need for greater
integration of sexual and reproductive health services and
services for HIV prevention, care and treatment [6,42],
most of the studies included in this review were based on
secondary analyses of data collected for other primary
purposes. As the need to integrate services for sexual
and reproductive health with services for HIV prevention
becomes more empirically supported [43], and especially
as the need for greater attention to preventing unintended
pregnancies in women living with HIV increases, it will
become more important that the provision of integrated
services is well understood and that evaluations of their
effectiveness are well designed and implemented [44].
Studies of interventions that are informed by the repro-
ductive desires and perspectives of women on living with
HIV, the barriers and challenges they face and their need
for long term support will be valuable. Studies that
measure not only contraception use at one point in time
but over time, that address not only pregnancy incidence
but the incidence of unintended pregnancy and that can
measure or detect the effects of treatment availability
and use on women’s perspectives and understandings of
mother to child transmission are essential as well. At-
tempting to reach the goal of elimination of HIV infections
in infants will surely benefit from using the full range of
interventions available, including an intensified focus
on the reduction of unintended pregnancies in women
living with HIV. Family planning counselling is but one
intervention needed to meet that goal, but it is an import-
ant one and it is insufficiently studied and understood.Endnote
aThe interventions recommended by WHO for the
prevention of mother to child transmission are: primary
prevention of HIV infection among women of childbear-
ing age; preventing unintended pregnancies among women
living with HIV; preventing HIV transmission from a
woman living with HIV to her infant; and providing
appropriate treatment, care and support to mothers living
with HIV and their children and families [2].
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